MEREDITH PHAM: Open Payments
NPI 1477176246 · WOODLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 56 payments from 13 companies in 2025. Trend: 2023 $2,556 · 2024 $3,812 · 2025 $1,719
Food & beverage: $1,719
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $627 |
| ABBVIE INC. | 9 | $267 |
| Regeneron Healthcare Solutions, Inc. | 10 | $214 |
| Kerecis Limited | 1 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $124 |
| Amgen Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Janssen Biotech, Inc. | 3 | $55 |
| Organon LLC | 3 | $34 |
| Krystal Biotech Inc | 1 | $23 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, Kerecis SurgiClose, SPEVIGO, OTEZLA, RINVOQ, TREMFYA.
Industry payments across CA — which companies pay providers there.
